Our objective was to determine features of ventricular tachyarrhythmias triggering appropriate implantable cardioverter-defibrillator (ICD) interventions in hypertrophic cardiomyopathy (HCM)
ObjectivesOur aim was to determine whether myocardial fibrosis, detected by cardiovascular magnetic ...
Background Hypertrophic cardiomyopathy (HCM) is a heterogeneous disease associated with arrhythmias....
Sudden cardiac death (SCD) is the most devastating complication of hypertrophic cardiomyopathy (HCM)...
Our objective was to determine features of ventricular tachyarrhythmias triggering appropriate impla...
Background. Patients with hypertrophic cardiomyopathy (HCM) frequently have arrhythmias and hemodyna...
International audiencePrimary hypertrophic cardiomyopathy is a genetic disease causing sarcomere dys...
ObjectivesThe goal of this study was to assemble a profile and assess the significance of arrhythmia...
Patients with hypertrophic cardiomyopathy may present with a number of arrhythmias. Although not uni...
Recurrent presyncope is occasionally reported by patients with hypertrophic cardiomyopathy (HC). How...
Hypertrophic cardiomyopathy is a genetic and heterogeneous disease with diverse clinical course, but...
In an era of rapid technological development and evolving diagnostic possibilities, the electrocardi...
NSVT in ICD Patients with HCM: Background: Nonsustained ventricular tachycardia (NSVT) is a risk fac...
In an era of rapid technological development and evolving diagnostic possibilities, the electrocardi...
AbstractObjectives. We report the occurrence of cardiac events during long-term follow-up in patient...
ABSTRACT: Implantable cardiac defibrillators (ICD) are greatly efficient in eliminating arrhythmias ...
ObjectivesOur aim was to determine whether myocardial fibrosis, detected by cardiovascular magnetic ...
Background Hypertrophic cardiomyopathy (HCM) is a heterogeneous disease associated with arrhythmias....
Sudden cardiac death (SCD) is the most devastating complication of hypertrophic cardiomyopathy (HCM)...
Our objective was to determine features of ventricular tachyarrhythmias triggering appropriate impla...
Background. Patients with hypertrophic cardiomyopathy (HCM) frequently have arrhythmias and hemodyna...
International audiencePrimary hypertrophic cardiomyopathy is a genetic disease causing sarcomere dys...
ObjectivesThe goal of this study was to assemble a profile and assess the significance of arrhythmia...
Patients with hypertrophic cardiomyopathy may present with a number of arrhythmias. Although not uni...
Recurrent presyncope is occasionally reported by patients with hypertrophic cardiomyopathy (HC). How...
Hypertrophic cardiomyopathy is a genetic and heterogeneous disease with diverse clinical course, but...
In an era of rapid technological development and evolving diagnostic possibilities, the electrocardi...
NSVT in ICD Patients with HCM: Background: Nonsustained ventricular tachycardia (NSVT) is a risk fac...
In an era of rapid technological development and evolving diagnostic possibilities, the electrocardi...
AbstractObjectives. We report the occurrence of cardiac events during long-term follow-up in patient...
ABSTRACT: Implantable cardiac defibrillators (ICD) are greatly efficient in eliminating arrhythmias ...
ObjectivesOur aim was to determine whether myocardial fibrosis, detected by cardiovascular magnetic ...
Background Hypertrophic cardiomyopathy (HCM) is a heterogeneous disease associated with arrhythmias....
Sudden cardiac death (SCD) is the most devastating complication of hypertrophic cardiomyopathy (HCM)...